Please assess the completion status of the following clinical trial:

Trial Title: Motor-Sparing Femoral Nerve Block Dose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18 and 75 years~* American Society of Anesthesiologists classification 1-3~* Body mass index between 20 and 35~Exclusion Criteria:~* Adults who are unable to give their own consent~* Pre-existing neuropathy (assessed by history and physical examination)~* Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets≤ 100, International Normalized Ratio≥ 1.4 or partial prothrombin time ≥ 50)~* Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)~* Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)~* Allergy to LA~* Pregnancy~* Prior surgery in the inguinal region~* Chronic pain syndromes requiring opioid intake at home

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- same dose (Type: EXPERIMENTAL): patient is exposed to the same previously successful dose
- lower dose (Type: EXPERIMENTAL): patient is exposed to a lower concentration dose

Based on this trial design, predict the completion outcome and termination type (if applicable).